四面体框架核酸可以调节介质素-17通路以缓解炎症并抑制结性脊柱炎中的异型骨化
Lihang Wang1,2, Yun Wang3, Yang Jiang4
1Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, No. 37 GuoXue Road, Chengdu 610041, China.
ACS nano
|November 20, 2023
概括
四面体框架核酸 (tFNAs) 在治疗结性脊髓炎 (AS) 方面表现有前途. 这些纳米材料抑制炎症和骨生长,有可能阻止AS的进展,并提供一种非手术疗法.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 类风湿病学 类风湿病学
背景情况:
- 脊髓缩性脊柱炎 (AS) 是一种慢性炎症性疾病,导致脊柱形和硬.
- 目前的治疗方法旨在控制炎症和症状,但不能阻止疾病的进展.
研究的目的:
- 研究四面体框架核酸 (tFNA) 在结性脊髓炎中的治疗潜力.
- 评估tFNAs对AS炎症反应和冠状细胞行为的影响.
主要方法:
- 在体内研究以评估tFNAs对炎症和异型骨化的影响.
- 在体外实验中使用AS患者的原发性冠状细胞来分析细胞行为和细胞因子分泌.
- 研究了介素-17通路和骨质生成的转录调节.
主要成果:
- 在体内,tFNAs治疗抑制了炎症反应和异型骨化,阻止了疾病的进展.
- 在体外,tFNAs调节了AS冠状细胞的行为,通过IL-17通路抑制了促炎性细胞因子分泌.
- 软骨细胞中的骨质生成过程在转录水平上被抑制.
结论:
- 四面体框架核酸在结性脊髓炎中显示出显著的治疗潜力.
- tFNAs可能成为未来的非手术治疗选择,以管理AS进展及其相关并发症.
相关概念视频
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
Autoimmune Disorders
449
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
449
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
146
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
146


